These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 3485460)
1. Impaired expression of cell surface receptors for B cell growth factor by chronic lymphocytic leukemia B cells. Perri RT Blood; 1986 Apr; 67(4):943-8. PubMed ID: 3485460 [TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of B-cell growth factor receptor reactivity in healthy donors and in patients with chronic lymphatic leukemia: relationship to B-cell-derived lymphokines. Benjamin D; Bazar LS; Wallace B; Jacobson RJ Cell Immunol; 1986 Dec; 103(2):394-408. PubMed ID: 3100061 [TBL] [Abstract][Full Text] [Related]
3. Large granular lymphocytes from B-chronic lymphocytic leukemia patients inhibit normal B cell proliferation. Perri RT; Kay NE Am J Hematol; 1989 Jul; 31(3):166-72. PubMed ID: 2500849 [TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of a B cell growth inhibitory factor (BIF) on BCGF-dependent B cell proliferation. Kawano M; Iwato K; Kuramoto A J Immunol; 1985 Jan; 134(1):375-81. PubMed ID: 3871108 [TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of responsiveness of chronic lymphocytic leukemic B cells to B cell growth factor or interleukin 2. Hivroz C; Grillot-Courvalin C; Brouet JC; Seligmann M Eur J Immunol; 1986 Aug; 16(8):1001-4. PubMed ID: 3488907 [TBL] [Abstract][Full Text] [Related]
7. Detection and characterization of human high molecular weight B cell growth factor receptors on leukemic B cells in chronic lymphocytic leukemia. Uckun FM; Fauci AS; Chandan-Langlie M; Myers DE; Ambrus JL J Clin Invest; 1989 Nov; 84(5):1595-608. PubMed ID: 2681271 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of B cell growth factor (BCGF) by monoclonal antibodies directed against the C3d receptor (CR2). Perri RT; Wilson BS; Kay NE Eur J Immunol; 1986 Apr; 16(4):350-5. PubMed ID: 2938967 [TBL] [Abstract][Full Text] [Related]
9. Human B cell responsiveness to B cell growth factor after activation by phorbol ester and monoclonal anti-mu antibody. Suzuki T; Butler JL; Cooper MD J Immunol; 1985 Apr; 134(4):2470-6. PubMed ID: 2982946 [TBL] [Abstract][Full Text] [Related]
10. Augmentation of normal and malignant B cell proliferation by monoclonal antibody to the B cell-specific antigen BP50 (CDW40). Ledbetter JA; Shu G; Gallagher M; Clark EA J Immunol; 1987 Feb; 138(3):788-94. PubMed ID: 3492534 [TBL] [Abstract][Full Text] [Related]
11. A case of human B cell leukemia that implicates an autocrine mechanism in the abnormal growth of Leu 1 B cells. Kawamura N; Muraguchi A; Hori A; Horii Y; Mutsuura S; Hardy RR; Kikutani H; Kishimoto T J Clin Invest; 1986 Nov; 78(5):1331-8. PubMed ID: 3490495 [TBL] [Abstract][Full Text] [Related]
12. Synergy of B cell growth factor and interleukin 2 in the proliferation of activated human B cells. Romagnani S; Giudizi GM; Maggi E; Almerigogna F; Biagiotti R; Del Prete G; Mazzetti M; Alessi A; Vercelli D; Ricci M Eur J Immunol; 1985 Dec; 15(12):1158-64. PubMed ID: 3936718 [TBL] [Abstract][Full Text] [Related]
13. Establishment of a human B cell line that proliferates in response to B cell growth factor. Abe H; Rossio JL; Ruscetti FW; Matsushima K; Oppenheim JJ J Immunol Methods; 1986 Jun; 90(1):111-23. PubMed ID: 2423613 [TBL] [Abstract][Full Text] [Related]
14. Production of B-cell growth factor interleukin 2 and gamma interferon by peripheral blood lymphocytes from patients with chronic lymphocytic leukemia of B-cell type. Rossi JF; Commes T; Grenier J; Jourdan M; Chichehian B; Klein B Am J Hematol; 1988 Dec; 29(4):183-8. PubMed ID: 3142255 [TBL] [Abstract][Full Text] [Related]
15. Surface immunoglobulins are involved in the interaction of protein A with human B cells and in the triggering of B cell proliferation induced by protein A-containing Staphylococcus aureus. Romagnani S; Giudizi MG; Biagiotti R; Almerigogna F; Maggi E; Del Prete G; Ricci M J Immunol; 1981 Oct; 127(4):1307-13. PubMed ID: 6974188 [TBL] [Abstract][Full Text] [Related]
16. Characterization of monoclonal B cell growth factor (BCGF) produced by a human T-T hybridoma. Butler JL; Ambrus JL; Fauci AS J Immunol; 1984 Jul; 133(1):251-5. PubMed ID: 6427336 [TBL] [Abstract][Full Text] [Related]
17. B cell growth and differentiation factors interact with receptors distinct from the interleukin 2 receptor. Kehrl JH; Grove JH; Goldsmith PK; Fauci AS Eur J Immunol; 1986 Jul; 16(7):761-6. PubMed ID: 3013645 [TBL] [Abstract][Full Text] [Related]
18. Different reactivity of activated human B cells to B-cell growth factor and interleukin 2 in the costimulation assay with anti-IgM antibody and in the preactivation assay with Staphylococcus bacteria. Almerigogna F; Biagiotti R; Giudizi GM; Del Prete GF; Maggi E; Mazzetti M; Alessi A; Ricci M; Romagnani S Cell Immunol; 1985 Oct; 95(2):358-67. PubMed ID: 3876163 [TBL] [Abstract][Full Text] [Related]
19. Regulation of B cell activation and differentiation with factors generated by human T cell hybridomas. Mayer L; Fu SM; Kunkel HG Immunol Rev; 1984 Apr; 78():119-35. PubMed ID: 6234220 [TBL] [Abstract][Full Text] [Related]
20. Stimulation of B-chronic lymphocytic leukemia populations by recombinant interleukin-4 and other defined growth-promoting agents. Ghaderi AA; Richardson P; Cardona C; Millsum MJ; Ling N; Gillis S; Ledbetter J; Gordon J Leukemia; 1988 Mar; 2(3):165-70. PubMed ID: 3126369 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]